Zydus Lifesciences hits new high on USFDA nod for drug with sales of $2 bn

Quick Summary:

Zydus Lifesciences stock surged as much as 2.61 per cent, hitting its all time high at Rs 1,313.

The drug will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ - II, India, the company said in an exchange filing on Friday.

Zydus Lifesciences is presently trading at a price to earnings multiple of 37.41 times, while trading at an earning per share (EPS) of Rs 34.20.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaUnited States

Topics: Zydus lifesciences share price today Zydus lifesciences share price Zydus lifesciences shares Stock market Sensex Zydus lifesciences share price Zydus lifesciences Valbenazine capsules Usfda drug approval Buzzing stock Usfda

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-09 @ 13:00:27 (16 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 422 words

Reading Time: 3 minutes read

Sentences: 16 lines

Sentence Length: 27 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21996967

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 303 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 4 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions